New type 2 diabetes mellitus (T2DM) guidelines have moved from a glycemic-based to an outcome-based approach, recommending treatments based on patient comorbidities. Sodium-glucose cotransporter-2 ...
Within 12 weeks, systolic blood pressure is reduced by 5 mm Hg, uACR by 30% and weight by 2 kg.4 Testing eGFR is not required after starting SGLT2 inhibitors except in patients at risk of volume ...
About The Study: Within the studied participants, there were clear absolute benefits of sodium-glucose cotransporter 2 (SGLT2) inhibitors on kidney, hospitalization, and mortality outcomes ...
DTx-based cardio-oncology rehabilitation for lung cancer survivors: A randomized controlled trial. a After propensity score matching by incorporating variables: age, sex, metastatic disease, androgen ...
Efficacy and safety of fruquintinib plus investigator's choice of chemotherapy as second-line therapy in metastatic colorectal cancer: A multicenter, single-arm phase 2 trial. a Adjusted for age, sex, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results